<!doctype html><html lang=fr><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide, des rÃ©sultats inÃ©dits sur le cÅ“ur Â» | Mounjaro News</title><meta name=description content="Le Mounjaro pourrait offrir des bÃ©nÃ©fices cardiovasculaires jamais observÃ©s auparavant."><meta name=author content="Mounjaro News"><meta name=keywords content="Mounjaro,tirzÃ©patide,tirzepatide,GLP-1,Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide,des rÃ©sultats inÃ©dits sur le cÅ“ur Â»"><meta name=robots content="index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1"><meta name=language content="fr"><meta name=revisit-after content="1 day"><link rel=canonical href=https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/><link rel=alternate hreflang=fr href=https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/><link rel=alternate hreflang=en href=https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/><link rel=alternate hreflang=x-default href=https://mounjaronews.info/><meta property="og:site_name" content="Mounjaro News"><meta property="og:title" content="Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide, des rÃ©sultats inÃ©dits sur le cÅ“ur Â» | Mounjaro News"><meta property="og:description" content="Le Mounjaro pourrait offrir des bÃ©nÃ©fices cardiovasculaires jamais observÃ©s auparavant."><meta property="og:url" content="https://mounjaronews.info/posts/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati/"><meta property="og:locale" content="fr_FR"><meta property="og:locale:alternate" content="en_US"><meta property="og:type" content="article"><meta property="article:published_time" content="2026-03-01T18:18:06+01:00"><meta property="article:modified_time" content="2026-03-01T18:18:06+01:00"><meta property="article:author" content="Mounjaro News"><meta property="article:section" content="SantÃ© / Health"><meta property="article:tag" content="Mounjaro"><meta property="article:tag" content="TirzÃ©patide"><meta property="article:tag" content="GLP-1"><meta property="article:tag" content="DiabÃ¨te"><meta property="article:tag" content="Perte de poids"><meta name=twitter:card content="summary_large_image"><meta name=twitter:title content="Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide, des rÃ©sultats inÃ©dits sur le cÅ“ur Â» | Mounjaro News"><meta name=twitter:description content="Le Mounjaro pourrait offrir des bÃ©nÃ©fices cardiovasculaires jamais observÃ©s auparavant."><script type=application/ld+json>{"@context":"https://schema.org","@type":"WebSite","name":"Mounjaro News","url":"https:\/\/mounjaronews.info\/","description":"Toute l\u0027actualitÃ© du Mounjaro (tirzÃ©patide) â€” articles reformulÃ©s et traduits chaque jour par IA","inLanguage":["fr-FR","en-US"],"about":{"@type":"Drug","name":"Tirzepatide","alternateName":["Mounjaro","Zepbound"],"sameAs":"https://www.wikidata.org/wiki/Q113523571"}}</script><script type=application/ld+json>{"@context":"https://schema.org","@type":"NewsArticle","headline":"\"Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide, des rÃ©sultats inÃ©dits sur le cÅ“ur Â»\"","description":"\"Le Mounjaro pourrait offrir des bÃ©nÃ©fices cardiovasculaires jamais observÃ©s auparavant.\"","datePublished":"2026-03-01T18:18:06\u002b01:00","dateModified":"2026-03-01T18:18:06\u002b01:00","inLanguage":["fr-FR","en-US"],"author":{"@type":"Organization","name":"Mounjaro News","url":"https:\/\/mounjaronews.info\/"},"publisher":{"@type":"Organization","name":"Mounjaro News","url":"https:\/\/mounjaronews.info\/"},"mainEntityOfPage":{"@type":"MedicalWebPage","@id":"https:\/\/mounjaronews.info\/posts\/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati\/","medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"}},"about":{"@type":"Drug","name":"Tirzepatide","alternateName":"Mounjaro"},"isBasedOn":{"@type":"NewsArticle","url":"\"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOU1ozWFNYRnpPbVBScWVud3BINm1PVTlMLXVPZUxvcUJJeEVKeUdBekJLc3RDQjVzLV9kNDhLY3M5aW1EVF9LTEhlQWRHTnB6VlpFRDc2VHpRUXRlaGNRc1VDbHE2WUVvVm9Pc1hMa1FRWGVsbS14SzZxa2VNVHg3eU5OREE4MmRBaHVkY0F4VGFGRmdWUmJBcWJvOU1GU0ZtRjZSMlFMSm4yb25qWkVZUGU2Z2ZpUHFzRThHN1pUZEdxek1QSHZ0Q1dLSGJQYl8xT0VyRjAtYzUwV1NWTmZLbXZrLXBnZmc?oc=5\""}}</script><script type=application/ld+json>{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mounjaronews.info\/"},{"@type":"ListItem","position":2,"name":"\"Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide, des rÃ©sultats inÃ©dits sur le cÅ“ur Â»\"","item":"https:\/\/mounjaronews.info\/posts\/2026-03-01-interview-exclusive-dr-myriam-rosilio-lilly-france-tirzepati\/"}]}</script><link rel=preconnect href=https://fonts.googleapis.com><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&display=swap" rel=stylesheet><link rel=stylesheet href=/css/style.css><script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-4796217302525352" crossorigin=anonymous></script><script async src=https://subscribe-forms.beehiiv.com/embed.js></script><link rel=icon type=image/svg+xml href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect width='100' height='100' rx='20' fill='%232563eb'/><text y='68' x='50' text-anchor='middle' font-size='38' font-family='system-ui' font-weight='800' fill='white'>MNJ</text></svg>"></head><body><header class=site-header><nav class=site-nav><a href=/ class=site-logo><div class=logo-icon>MNJ</div><div class=logo-text><span class=logo-name>Mounjaro News</span>
<span class=logo-sub>ActualitÃ©s tirzÃ©patide Â· FR & EN</span></div></a><ul class=nav-links><li><a href=/>Accueil</a></li><li><a href=https://www.mounjaro.com target=_blank rel=noopener>Mounjaro.com</a></li><li><a href=/#newsletter class=nav-pill>Newsletter gratuite</a></li></ul></nav></header><div class=article-header><div class=article-header-inner><a href=/ class=back-link>â† Retour Â· Back</a><div class=article-label>ğŸ’Š Mounjaro Â· TirzÃ©patide</div><h1>Interview exclusive â€” Dr Myriam Rosilio (Lilly France) : Â« TirzÃ©patide, des rÃ©sultats inÃ©dits sur le cÅ“ur Â»</h1><div class=article-meta><span class=meta-chip>ğŸ“… 1 March 2026</span>
<span class=meta-chip>ğŸ“° news.google.com</span>
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOU1ozWFNYRnpPbVBScWVud3BINm1PVTlMLXVPZUxvcUJJeEVKeUdBekJLc3RDQjVzLV9kNDhLY3M5aW1EVF9LTEhlQWRHTnB6VlpFRDc2VHpRUXRlaGNRc1VDbHE2WUVvVm9Pc1hMa1FRWGVsbS14SzZxa2VNVHg3eU5OREE4MmRBaHVkY0F4VGFGRmdWUmJBcWJvOU1GU0ZtRjZSMlFMSm4yb25qWkVZUGU2Z2ZpUHFzRThHN1pUZEdxek1QSHZ0Q1dLSGJQYl8xT0VyRjAtYzUwV1NWTmZLbXZrLXBnZmc?oc=5" target=_blank rel="noopener noreferrer" class=source-link>ğŸ”— Source originale</a></div></div></div><div class=article-body><div class=ad-wrapper><p class=ad-label>PublicitÃ©</p><ins class=adsbygoogle style=display:block;text-align:center data-ad-layout=in-article data-ad-format=fluid data-ad-client=ca-pub-4796217302525352 data-ad-slot=auto></ins><script>(adsbygoogle=window.adsbygoogle||[]).push({})</script></div><div class=lang-switcher id=langSwitcher><button class="lang-btn active" data-lang=fr onclick='switchLang("fr")'>
ğŸ‡«ğŸ‡· FranÃ§ais
</button>
<button class=lang-btn data-lang=en onclick='switchLang("en")'>
ğŸ‡¬ğŸ‡§ English</button></div><div class=bilingual-grid><div class=lang-block id=block-fr><div class=lang-header><span class=lang-flag>ğŸ‡«ğŸ‡·</span> Version franÃ§aise</div><div class=lang-content>Le Mounjaro pourrait offrir des bÃ©nÃ©fices cardiovasculaires jamais observÃ©s auparavant. Selon le Dr Myriam Rosilio, directrice mÃ©dicale de Eli Lilly France, la tirzÃ©patide, principe actif du Mounjaro, dÃ©montre des effets protecteurs sur le cÅ“ur au-delÃ  de sa simple action sur le poids. Ce mÃ©dicament appartient Ã  la classe des agonistes GLP-1 et GIP, des hormones naturelles qui rÃ©gulent l&rsquo;appÃ©tit et la glycÃ©mie. Les derniÃ¨res donnÃ©es cliniques rÃ©vÃ¨lent une rÃ©duction significative des Ã©vÃ©nements cardiovasculaires chez les patients diabÃ©tiques de type 2 traitÃ©s par tirzÃ©patide. Le Dr Rosilio explique que ces rÃ©sultats dÃ©passent les attentes initiales et ouvrent de nouvelles perspectives thÃ©rapeutiques. Au-delÃ  de la perte de poids, le mÃ©dicament semble rÃ©duire l&rsquo;inflammation et amÃ©liorer la fonction cardiaque. Ces dÃ©couvertes pourraient modifier la stratÃ©gie de traitement chez les patients prÃ©sentant Ã  la fois un diabÃ¨te et des risques cardiaques Ã©levÃ©s. Cependant, des Ã©tudes supplÃ©mentaires restent nÃ©cessaires pour confirmer ces bÃ©nÃ©fices et identifier les populations qui en bÃ©nÃ©ficieraient le plus. Cette avancÃ©e reprÃ©sente une Ã©volution importante dans la prise en charge du diabÃ¨te de type 2, traditionnellement compliquÃ©e par les maladies cardiovasculaires.</div></div><div class=lang-block id=block-en><div class=lang-header><span class=lang-flag>ğŸ‡¬ğŸ‡§</span> English version</div><div class=lang-content>Mounjaro may offer unprecedented cardiovascular benefits previously unseen in this drug class. According to Dr. Myriam Rosilio, Medical Director at Eli Lilly France, tirzepatideâ€”the active ingredient in Mounjaroâ€”demonstrates protective effects on the heart beyond its weight management properties. This medication acts as a dual GLP-1 and GIP receptor agonist, mimicking natural hormones that regulate appetite and blood sugar. Recent clinical data show a substantial reduction in heart-related events among type 2 diabetic patients receiving tirzepatide treatment. Dr. Rosilio emphasizes these results exceeded initial expectations, opening new therapeutic possibilities. Beyond weight loss, the drug appears to reduce inflammation and enhance cardiac function. These findings may reshape treatment strategies for patients with both diabetes and high cardiovascular risk. Yet additional research is needed to validate these advantages and determine which patient populations would benefit most. This breakthrough represents significant progress in managing type 2 diabetes, which is traditionally complicated by cardiovascular disease. The combination of metabolic and heart health improvements makes tirzepatide particularly noteworthy for clinical practice.</div></div></div><div class=ad-wrapper><p class=ad-label>PublicitÃ©</p><ins class=adsbygoogle style=display:block;text-align:center data-ad-layout=in-article data-ad-format=fluid data-ad-client=ca-pub-4796217302525352 data-ad-slot=auto></ins><script>(adsbygoogle=window.adsbygoogle||[]).push({})</script></div><div class=newsletter-section><div class=newsletter-inner><div class=newsletter-icon>ğŸ“¬</div><h3>Recevez l'actu Mounjaro chaque matin</h3><p>Abonnez-vous gratuitement â€” rÃ©sumÃ© quotidien FR & EN dans votre boÃ®te mail.
<em>Subscribe free â€” daily FR & EN digest in your inbox.</em></p><iframe src=https://subscribe-forms.beehiiv.com/91587c2f-9b1e-45e3-95cf-1f8ca0fe3c4b class=beehiiv-embed data-test-id=beehiiv-embed frameborder=0 scrolling=no></iframe></div></div></div><script>function switchLang(e){const t=window.innerWidth<=700;if(!t)return;document.querySelectorAll(".lang-btn").forEach(t=>{t.classList.toggle("active",t.dataset.lang===e)}),document.getElementById("block-fr").style.display=e==="fr"?"":"none",document.getElementById("block-en").style.display=e==="en"?"":"none"}window.innerWidth<=700&&(document.getElementById("block-en").style.display="none"),window.addEventListener("resize",function(){window.innerWidth>700&&(document.getElementById("block-fr").style.display="",document.getElementById("block-en").style.display="")})</script><footer class=site-footer><div class=footer-inner><div class=footer-grid><div class=footer-brand><a href=/ class=site-logo><div class=logo-icon>MNJ</div><div class=logo-text><span class=logo-name style=color:rgba(255,255,255,.9)>Mounjaro News</span>
<span class=logo-sub>ActualitÃ©s tirzÃ©patide Â· FR & EN</span></div></a><p style=margin-top:14px>RÃ©sumÃ©s quotidiens des actualitÃ©s sur le Mounjaro (tirzÃ©patide), reformulÃ©s et traduits par intelligence artificielle. Pas de conseil mÃ©dical.</p></div><div class=footer-col><h4>Navigation</h4><ul><li><a href=/>Accueil</a></li><li><a href=/#newsletter>Newsletter</a></li><li><a href=https://mounjaronews.info/sitemap.xml target=_blank>Sitemap</a></li></ul></div><div class=footer-col><h4>Ressources</h4><ul><li><a href=https://www.mounjaro.com target=_blank rel=noopener>Mounjaro.com</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/?term=tirzepatide" target=_blank rel=noopener>PubMed</a></li><li><a href=https://www.ema.europa.eu target=_blank rel=noopener>EMA</a></li></ul></div></div><div class=footer-bottom><p class=footer-copy>&copy; 2026 Mounjaro News &nbsp;Â·&nbsp;
PropulsÃ© par <a href=https://www.anthropic.com target=_blank rel=noopener style=color:rgba(255,255,255,.6)>Claude AI</a></p><p class=footer-disclaimer>âš ï¸ Site d'information uniquement â€” pas de conseil mÃ©dical. Consultez toujours votre mÃ©decin.
For informational purposes only â€” not medical advice.</p></div></div></footer></body></html>